Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids

Atopic dermatitis (AD) is a chronic inflammatory disease requiring efficacious and safe long-term therapy. Several new systemic treatments have recently been approved for use in patients with moderate to severe AD. However, head-to-head comparisons have not been conducted for all the currently avail...

Descripción completa

Detalles Bibliográficos
Autores principales: Silverberg, Jonathan I., Armstrong, April, Blauvelt, Andrew, Reich, Kristian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570226/
https://www.ncbi.nlm.nih.gov/pubmed/37695504
http://dx.doi.org/10.1007/s40257-023-00809-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570226/
https://www.ncbi.nlm.nih.gov/pubmed/37695504
http://dx.doi.org/10.1007/s40257-023-00809-0

Ejemplares similares